Search alternatives:
improvement decrease » improvements increased (Expand Search), improvement success (Expand Search)
small decrease » small increased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
Showing 1 - 20 results of 10,517 for search '(( significant improvement decrease ) OR ( significant ((small decrease) OR (we decrease)) ))', query time: 0.71s Refine Results
  1. 1
    The linearly decreasing convergence factor a.

    The linearly decreasing convergence factor a. by Junhao Wei (6816803)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Visualization of heatmaps before and after improvement.

    Visualization of heatmaps before and after improvement. by Junyan Wang (4738518)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Comparison of effects before and after improvement.

    Comparison of effects before and after improvement. by Junyan Wang (4738518)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”
    Save to List
    Saved in:
  5. 5
    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”
    Save to List
    Saved in:
  6. 6
    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”
    Save to List
    Saved in:
  7. 7
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Overview of the WeARTolerance program.

    Overview of the WeARTolerance program. by Ana Beato (20489933)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 11
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Bluetooth beacons with colour coded lanyards.

    Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Summary of previous work.

    Summary of previous work. by Junyan Wang (4738518)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Comparison of MAP@0.5 results from experiments.

    Comparison of MAP@0.5 results from experiments. by Junyan Wang (4738518)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    YOLO11.

    YOLO11. by Junyan Wang (4738518)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Structure of the SCI-YOLO11 network.

    Structure of the SCI-YOLO11 network. by Junyan Wang (4738518)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Comparative experimental results.

    Comparative experimental results. by Junyan Wang (4738518)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Algorithm operation steps.

    Algorithm operation steps. by Junyan Wang (4738518)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: